IGFBP7 and acute kidney injury: Numerous studies in critically ill patients have demonstrated an incremental risk of AKI (stages 2 and 3) with a urinary [TIMP-2] × [IGFBP7] >0.3(ng/ml)2/103 [7, 8], but its association with PrAKI has not been assessed.